Clinical Trial Update: Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner [Phase 3]

View source ↗

Summary

Phase 3 trial investigating dietary anthocyanins improving lipid metabolism in a dose-dependent manner for dyslipidemias has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Snippet

Sponsor: Sun Yat-sen University | Conditions: Dyslipidemias | Phase 3 | Status: COMPLETED